nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—Hypoglycemic reaction—Lisinopril—dilated cardiomyopathy	0.0374	0.0374	CcSEcCtD
Zaleplon—Breast pain—Spironolactone—dilated cardiomyopathy	0.0192	0.0192	CcSEcCtD
Zaleplon—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.0141	0.0141	CcSEcCtD
Zaleplon—Bursitis—Lisinopril—dilated cardiomyopathy	0.0141	0.0141	CcSEcCtD
Zaleplon—Renal pain—Lisinopril—dilated cardiomyopathy	0.013	0.013	CcSEcCtD
Zaleplon—Apathy—Furosemide—dilated cardiomyopathy	0.0127	0.0127	CcSEcCtD
Zaleplon—Flat affect—Furosemide—dilated cardiomyopathy	0.0126	0.0126	CcSEcCtD
Zaleplon—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.0115	0.0115	CcSEcCtD
Zaleplon—Ataxia—Spironolactone—dilated cardiomyopathy	0.0114	0.0114	CcSEcCtD
Zaleplon—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0113	0.0113	CcSEcCtD
Zaleplon—Psoriasis—Lisinopril—dilated cardiomyopathy	0.0109	0.0109	CcSEcCtD
Zaleplon—Gastritis—Spironolactone—dilated cardiomyopathy	0.0107	0.0107	CcSEcCtD
Zaleplon—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.0105	0.0105	CcSEcCtD
Zaleplon—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Zaleplon—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.0098	0.0098	CcSEcCtD
Zaleplon—Gout—Furosemide—dilated cardiomyopathy	0.00974	0.00974	CcSEcCtD
Zaleplon—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00966	0.00966	CcSEcCtD
Zaleplon—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00946	0.00946	CcSEcCtD
Zaleplon—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00926	0.00926	CcSEcCtD
Zaleplon—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00891	0.00891	CcSEcCtD
Zaleplon—Bladder pain—Furosemide—dilated cardiomyopathy	0.00822	0.00822	CcSEcCtD
Zaleplon—Mental disability—Furosemide—dilated cardiomyopathy	0.00789	0.00789	CcSEcCtD
Zaleplon—Breast pain—Lisinopril—dilated cardiomyopathy	0.00782	0.00782	CcSEcCtD
Zaleplon—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00762	0.00762	CcSEcCtD
Zaleplon—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00759	0.00759	CcSEcCtD
Zaleplon—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00755	0.00755	CcSEcCtD
Zaleplon—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00752	0.00752	CcSEcCtD
Zaleplon—Arthropathy—Lisinopril—dilated cardiomyopathy	0.0075	0.0075	CcSEcCtD
Zaleplon—Swelling—Furosemide—dilated cardiomyopathy	0.00748	0.00748	CcSEcCtD
Zaleplon—Alopecia—Spironolactone—dilated cardiomyopathy	0.00742	0.00742	CcSEcCtD
Zaleplon—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00738	0.00738	CcSEcCtD
Zaleplon—Deafness—Furosemide—dilated cardiomyopathy	0.00738	0.00738	CcSEcCtD
Zaleplon—Gout—Lisinopril—dilated cardiomyopathy	0.00731	0.00731	CcSEcCtD
Zaleplon—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00726	0.00726	CcSEcCtD
Zaleplon—Thirst—Furosemide—dilated cardiomyopathy	0.00693	0.00693	CcSEcCtD
Zaleplon—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00691	0.00691	CcSEcCtD
Zaleplon—Purpura—Furosemide—dilated cardiomyopathy	0.00685	0.00685	CcSEcCtD
Zaleplon—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00682	0.00682	CcSEcCtD
Zaleplon—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00682	0.00682	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00682	0.00682	CcSEcCtD
Zaleplon—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00678	0.00678	CcSEcCtD
Zaleplon—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00666	0.00666	CcSEcCtD
Zaleplon—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00663	0.00663	CcSEcCtD
Zaleplon—Malaise—Spironolactone—dilated cardiomyopathy	0.00659	0.00659	CcSEcCtD
Zaleplon—Cystitis—Lisinopril—dilated cardiomyopathy	0.00659	0.00659	CcSEcCtD
Zaleplon—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00648	0.00648	CcSEcCtD
Zaleplon—Neuropathy—Lisinopril—dilated cardiomyopathy	0.0064	0.0064	CcSEcCtD
Zaleplon—Photophobia—Lisinopril—dilated cardiomyopathy	0.0064	0.0064	CcSEcCtD
Zaleplon—Irritability—Furosemide—dilated cardiomyopathy	0.0063	0.0063	CcSEcCtD
Zaleplon—Urinary retention—Furosemide—dilated cardiomyopathy	0.00628	0.00628	CcSEcCtD
Zaleplon—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00617	0.00617	CcSEcCtD
Zaleplon—Discomfort—Spironolactone—dilated cardiomyopathy	0.00615	0.00615	CcSEcCtD
Zaleplon—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00603	0.00603	CcSEcCtD
Zaleplon—Confusional state—Spironolactone—dilated cardiomyopathy	0.00601	0.00601	CcSEcCtD
Zaleplon—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00598	0.00598	CcSEcCtD
Zaleplon—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00596	0.00596	CcSEcCtD
Zaleplon—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00582	0.00582	CcSEcCtD
Zaleplon—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00569	0.00569	CcSEcCtD
Zaleplon—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00565	0.00565	CcSEcCtD
Zaleplon—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00564	0.00564	CcSEcCtD
Zaleplon—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00559	0.00559	CcSEcCtD
Zaleplon—Eczema—Lisinopril—dilated cardiomyopathy	0.00551	0.00551	CcSEcCtD
Zaleplon—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00534	0.00534	CcSEcCtD
Zaleplon—Somnolence—Spironolactone—dilated cardiomyopathy	0.0053	0.0053	CcSEcCtD
Zaleplon—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00527	0.00527	CcSEcCtD
Zaleplon—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00521	0.00521	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00515	0.00515	CcSEcCtD
Zaleplon—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00515	0.00515	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00512	0.00512	CcSEcCtD
Zaleplon—Arthritis—Lisinopril—dilated cardiomyopathy	0.0051	0.0051	CcSEcCtD
Zaleplon—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00507	0.00507	CcSEcCtD
Zaleplon—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00495	0.00495	CcSEcCtD
Zaleplon—Diplopia—Lisinopril—dilated cardiomyopathy	0.00495	0.00495	CcSEcCtD
Zaleplon—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00491	0.00491	CcSEcCtD
Zaleplon—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00491	0.00491	CcSEcCtD
Zaleplon—Sweating—Furosemide—dilated cardiomyopathy	0.00488	0.00488	CcSEcCtD
Zaleplon—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00481	0.00481	CcSEcCtD
Zaleplon—Face oedema—Lisinopril—dilated cardiomyopathy	0.00478	0.00478	CcSEcCtD
Zaleplon—Urticaria—Spironolactone—dilated cardiomyopathy	0.00474	0.00474	CcSEcCtD
Zaleplon—Irritability—Lisinopril—dilated cardiomyopathy	0.00473	0.00473	CcSEcCtD
Zaleplon—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00471	0.00471	CcSEcCtD
Zaleplon—Ataxia—Lisinopril—dilated cardiomyopathy	0.00466	0.00466	CcSEcCtD
Zaleplon—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00452	0.00452	CcSEcCtD
Zaleplon—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00447	0.00447	CcSEcCtD
Zaleplon—Visual impairment—Furosemide—dilated cardiomyopathy	0.0044	0.0044	CcSEcCtD
Zaleplon—Gastritis—Lisinopril—dilated cardiomyopathy	0.00438	0.00438	CcSEcCtD
Zaleplon—Asthma—Lisinopril—dilated cardiomyopathy	0.00428	0.00428	CcSEcCtD
Zaleplon—Eye disorder—Furosemide—dilated cardiomyopathy	0.00427	0.00427	CcSEcCtD
Zaleplon—Tinnitus—Furosemide—dilated cardiomyopathy	0.00426	0.00426	CcSEcCtD
Zaleplon—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00424	0.00424	CcSEcCtD
Zaleplon—Pruritus—Spironolactone—dilated cardiomyopathy	0.00422	0.00422	CcSEcCtD
Zaleplon—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00417	0.00417	CcSEcCtD
Zaleplon—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00412	0.00412	CcSEcCtD
Zaleplon—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00412	0.00412	CcSEcCtD
Zaleplon—Dysuria—Lisinopril—dilated cardiomyopathy	0.004	0.004	CcSEcCtD
Zaleplon—Malnutrition—Furosemide—dilated cardiomyopathy	0.00397	0.00397	CcSEcCtD
Zaleplon—Dizziness—Spironolactone—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Zaleplon—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Zaleplon—Flatulence—Furosemide—dilated cardiomyopathy	0.00392	0.00392	CcSEcCtD
Zaleplon—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00391	0.00391	CcSEcCtD
Zaleplon—Weight increased—Lisinopril—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Zaleplon—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00389	0.00389	CcSEcCtD
Zaleplon—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00387	0.00387	CcSEcCtD
Zaleplon—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00386	0.00386	CcSEcCtD
Zaleplon—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00384	0.00384	CcSEcCtD
Zaleplon—Depression—Lisinopril—dilated cardiomyopathy	0.00381	0.00381	CcSEcCtD
Zaleplon—Rash—Spironolactone—dilated cardiomyopathy	0.00376	0.00376	CcSEcCtD
Zaleplon—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00376	0.00376	CcSEcCtD
Zaleplon—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00374	0.00374	CcSEcCtD
Zaleplon—Headache—Spironolactone—dilated cardiomyopathy	0.00374	0.00374	CcSEcCtD
Zaleplon—Anaemia—Furosemide—dilated cardiomyopathy	0.00367	0.00367	CcSEcCtD
Zaleplon—Sweating—Lisinopril—dilated cardiomyopathy	0.00366	0.00366	CcSEcCtD
Zaleplon—Agitation—Furosemide—dilated cardiomyopathy	0.00365	0.00365	CcSEcCtD
Zaleplon—Haematuria—Lisinopril—dilated cardiomyopathy	0.00364	0.00364	CcSEcCtD
Zaleplon—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00361	0.00361	CcSEcCtD
Zaleplon—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0036	0.0036	CcSEcCtD
Zaleplon—Vertigo—Furosemide—dilated cardiomyopathy	0.00357	0.00357	CcSEcCtD
Zaleplon—Nausea—Spironolactone—dilated cardiomyopathy	0.00354	0.00354	CcSEcCtD
Zaleplon—Hallucination—Lisinopril—dilated cardiomyopathy	0.00341	0.00341	CcSEcCtD
Zaleplon—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00337	0.00337	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00336	0.00336	CcSEcCtD
Zaleplon—Dry mouth—Furosemide—dilated cardiomyopathy	0.00331	0.00331	CcSEcCtD
Zaleplon—Confusional state—Furosemide—dilated cardiomyopathy	0.00327	0.00327	CcSEcCtD
Zaleplon—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00324	0.00324	CcSEcCtD
Zaleplon—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00319	0.00319	CcSEcCtD
Zaleplon—Shock—Furosemide—dilated cardiomyopathy	0.00319	0.00319	CcSEcCtD
Zaleplon—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00318	0.00318	CcSEcCtD
Zaleplon—Skin disorder—Furosemide—dilated cardiomyopathy	0.00315	0.00315	CcSEcCtD
Zaleplon—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00314	0.00314	CcSEcCtD
Zaleplon—Anorexia—Furosemide—dilated cardiomyopathy	0.00309	0.00309	CcSEcCtD
Zaleplon—Chills—Lisinopril—dilated cardiomyopathy	0.00307	0.00307	CcSEcCtD
Zaleplon—Hypotension—Furosemide—dilated cardiomyopathy	0.00303	0.00303	CcSEcCtD
Zaleplon—Alopecia—Lisinopril—dilated cardiomyopathy	0.00303	0.00303	CcSEcCtD
Zaleplon—Mental disorder—Lisinopril—dilated cardiomyopathy	0.003	0.003	CcSEcCtD
Zaleplon—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Zaleplon—Flatulence—Lisinopril—dilated cardiomyopathy	0.00294	0.00294	CcSEcCtD
Zaleplon—Tension—Lisinopril—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Zaleplon—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00292	0.00292	CcSEcCtD
Zaleplon—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00291	0.00291	CcSEcCtD
Zaleplon—Nervousness—Lisinopril—dilated cardiomyopathy	0.0029	0.0029	CcSEcCtD
Zaleplon—Back pain—Lisinopril—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Zaleplon—Somnolence—Furosemide—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Zaleplon—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00282	0.00282	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Zaleplon—Tremor—Lisinopril—dilated cardiomyopathy	0.00279	0.00279	CcSEcCtD
Zaleplon—Constipation—Furosemide—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Zaleplon—Pain—Furosemide—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Zaleplon—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00277	0.00277	CcSEcCtD
Zaleplon—Anaemia—Lisinopril—dilated cardiomyopathy	0.00276	0.00276	CcSEcCtD
Zaleplon—Angioedema—Lisinopril—dilated cardiomyopathy	0.00272	0.00272	CcSEcCtD
Zaleplon—Malaise—Lisinopril—dilated cardiomyopathy	0.00269	0.00269	CcSEcCtD
Zaleplon—Vertigo—Lisinopril—dilated cardiomyopathy	0.00268	0.00268	CcSEcCtD
Zaleplon—Syncope—Lisinopril—dilated cardiomyopathy	0.00267	0.00267	CcSEcCtD
Zaleplon—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00267	0.00267	CcSEcCtD
Zaleplon—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00265	0.00265	CcSEcCtD
Zaleplon—Palpitations—Lisinopril—dilated cardiomyopathy	0.00264	0.00264	CcSEcCtD
Zaleplon—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00262	0.00262	CcSEcCtD
Zaleplon—Urticaria—Furosemide—dilated cardiomyopathy	0.00258	0.00258	CcSEcCtD
Zaleplon—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00256	0.00256	CcSEcCtD
Zaleplon—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00256	0.00256	CcSEcCtD
Zaleplon—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00254	0.00254	CcSEcCtD
Zaleplon—Myalgia—Lisinopril—dilated cardiomyopathy	0.00254	0.00254	CcSEcCtD
Zaleplon—Chest pain—Lisinopril—dilated cardiomyopathy	0.00254	0.00254	CcSEcCtD
Zaleplon—Anxiety—Lisinopril—dilated cardiomyopathy	0.00253	0.00253	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00252	0.00252	CcSEcCtD
Zaleplon—Discomfort—Lisinopril—dilated cardiomyopathy	0.00251	0.00251	CcSEcCtD
Zaleplon—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00248	0.00248	CcSEcCtD
Zaleplon—Confusional state—Lisinopril—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Zaleplon—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00243	0.00243	CcSEcCtD
Zaleplon—Oedema—Lisinopril—dilated cardiomyopathy	0.00243	0.00243	CcSEcCtD
Zaleplon—Shock—Lisinopril—dilated cardiomyopathy	0.00239	0.00239	CcSEcCtD
Zaleplon—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00238	0.00238	CcSEcCtD
Zaleplon—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00236	0.00236	CcSEcCtD
Zaleplon—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00235	0.00235	CcSEcCtD
Zaleplon—Asthenia—Furosemide—dilated cardiomyopathy	0.00233	0.00233	CcSEcCtD
Zaleplon—Anorexia—Lisinopril—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Zaleplon—Pruritus—Furosemide—dilated cardiomyopathy	0.00229	0.00229	CcSEcCtD
Zaleplon—Hypotension—Lisinopril—dilated cardiomyopathy	0.00227	0.00227	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00222	0.00222	CcSEcCtD
Zaleplon—Insomnia—Lisinopril—dilated cardiomyopathy	0.0022	0.0022	CcSEcCtD
Zaleplon—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00219	0.00219	CcSEcCtD
Zaleplon—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00217	0.00217	CcSEcCtD
Zaleplon—Somnolence—Lisinopril—dilated cardiomyopathy	0.00216	0.00216	CcSEcCtD
Zaleplon—Dizziness—Furosemide—dilated cardiomyopathy	0.00215	0.00215	CcSEcCtD
Zaleplon—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00214	0.00214	CcSEcCtD
Zaleplon—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00212	0.00212	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0021	0.0021	CcSEcCtD
Zaleplon—Constipation—Lisinopril—dilated cardiomyopathy	0.00208	0.00208	CcSEcCtD
Zaleplon—Pain—Lisinopril—dilated cardiomyopathy	0.00208	0.00208	CcSEcCtD
Zaleplon—Rash—Furosemide—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Zaleplon—Dermatitis—Furosemide—dilated cardiomyopathy	0.00204	0.00204	CcSEcCtD
Zaleplon—Headache—Furosemide—dilated cardiomyopathy	0.00203	0.00203	CcSEcCtD
Zaleplon—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00201	0.00201	CcSEcCtD
Zaleplon—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00199	0.00199	CcSEcCtD
Zaleplon—Urticaria—Lisinopril—dilated cardiomyopathy	0.00193	0.00193	CcSEcCtD
Zaleplon—Nausea—Furosemide—dilated cardiomyopathy	0.00193	0.00193	CcSEcCtD
Zaleplon—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00192	0.00192	CcSEcCtD
Zaleplon—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00192	0.00192	CcSEcCtD
Zaleplon—Asthenia—Lisinopril—dilated cardiomyopathy	0.00175	0.00175	CcSEcCtD
Zaleplon—Pruritus—Lisinopril—dilated cardiomyopathy	0.00172	0.00172	CcSEcCtD
Zaleplon—Dizziness—Lisinopril—dilated cardiomyopathy	0.00161	0.00161	CcSEcCtD
Zaleplon—Rash—Lisinopril—dilated cardiomyopathy	0.00153	0.00153	CcSEcCtD
Zaleplon—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00153	0.00153	CcSEcCtD
Zaleplon—Headache—Lisinopril—dilated cardiomyopathy	0.00152	0.00152	CcSEcCtD
Zaleplon—Nausea—Lisinopril—dilated cardiomyopathy	0.00145	0.00145	CcSEcCtD
